Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

Xalkori set for rapid review in new lung cancer indication

Pfizer could produce first FDA-approved biomarker-driven therapy for ROS1-positive NSCLC

- PMLiVE

Katja Stout joins Citigate Dewe Rogerson

The former AstraZeneca vice president will serve as a director in its life sciences team

- PMLiVE

Pfizer signs $1bn cancer antibody deal with BioAtla

Aims to overcome one of the limitations of antibody-drug conjugate drugs

Projects selected for MSD-backed digital accelerator

Disease-specific mobile apps among those winning support from Velocity Health

- PMLiVE

Mixed news for gene therapies at ASH conference

GSK unveils successful trial, but there was disappointing news for Bluebird

- PMLiVE

A balanced multichannel communications process

Uncover the customer experience and reflect it in your strategy

- PMLiVE

Merck abandons evofosfamide as two trials fail

Solid tumour candidate underwhelms in phase III studies

- PMLiVE

UK patients get early access to AZ’s lung cancer drug Tagrisso

The treatment is the fourth made available under the EAMS

- PMLiVE

PureTech appoints Joseph Bolen as entrepreneur-in-residence

And Vincent Hennemand joins as VP, company development and operations

- PMLiVE

Avanti Ananthram to lead Narrative Health’s new US office

She will lead its New York office as its managing director

- PMLiVE

First von Willebrand disease therapy heads new FDA approvals

Baxalta's Vonvendi set for an early 2016 launch in the US

- PMLiVE

Novel therapies for blood cancers showcased at ASH

Novartis' lead CAR-T therapy is one of those in the spotlight

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links